<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>44(1)</volume><submitter>Zhang L</submitter><funding>National Natural Science Foundation of China</funding><journal>Journal of experimental &amp; clinical cancer research : CR</journal><pagination>272</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12487002</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>PSMA-targeted theranostic nanoplatform achieves spatiotemporally precise therapy and triggers ferroptosis in prostate cancer treatment.</pubmed_title><pmcid>PMC12487002</pmcid><funding_grant_id>No. 82404007</funding_grant_id><pubmed_authors>Sun Q</pubmed_authors><pubmed_authors>Huang X</pubmed_authors><pubmed_authors>Liu R</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Yu Z</pubmed_authors><pubmed_authors>Xiong W</pubmed_authors><pubmed_authors>Zheng D</pubmed_authors><pubmed_authors>Lan Z</pubmed_authors><pubmed_authors>Sun K</pubmed_authors></additional><is_claimable>false</is_claimable><name>PSMA-targeted theranostic nanoplatform achieves spatiotemporally precise therapy and triggers ferroptosis in prostate cancer treatment.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-04T00:23:56.226Z</modification><creation>2026-05-03T03:12:35.893Z</creation></dates><accession>S-EPMC12487002</accession><cross_references><pubmed>41029459</pubmed><doi>10.1186/s13046-025-03530-4</doi></cross_references></HashMap>